DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES
Currently, a greater emphasis is placed on the search for additional biomarkers of chronic heart failure (CHF). Galectin-3, a marker of fibrosis and inflammation, has shown himself as a biomarker of CHF in many studies, but the dynamics of its levels in patients with concomitant diabetes mellitus (D...
Main Authors: | A. A. Snetkova, N. Yu. Timofeeva, V. S. Zadionchenko |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2015-09-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/78 |
Similar Items
-
DIAGNOSTIC VALUE OF GALECTIN-3 LEVEL IN PATIENTS WITH CHRONIC HEART FAILURE AND TYPE 2 DIABETES
by: A. A. Snetkova, et al.
Published: (2015-09-01) -
Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024-02-01) -
Evaluation of the relationship of immuno-inflammatory process with dyslipidemia and myocardial morphofunctional parameters in patients with chronic heart failure on the background of rheumatoid arthritis
by: A. S. Ankudinov, et al.
Published: (2020-09-01) -
AFFECTIVE DISORDERS IN PATIENTS WITH DIASTOLIC CHRONIC HEART FAILURE
by: V. A. Lusov, et al.
Published: (2010-06-01) -
NEBIVOLOL ROLE IN THE CORRECTION OF INTRACARDIAC HEMODYNAMICS IN PATIENTS WITH CHRONIC HEART FAILURE
by: R. L. Dzhanaeva, et al.
Published: (2012-02-01)